Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPRING trial of intravesical gentamicin for prevention of recurrent multidrug-resistant urinary tract infections
NL-OMON38402Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Apr 2014
- Modality
- Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Randomised, open-label trial of gentamicin in urinary tract infection (UTI), cystitis and chronic bacterial prostatitis (CBP) (3 arms), sponsored by Leiden University Medical Center. Primary endpoint: Number of urinary tract infections per patient. Started Apr 2014; status: active, not recruiting.
02
Drugs
gentamicin
03
Conditions
urinary tract infection (UTI)cystitischronic bacterial prostatitis (CBP)
Beyond the preview
Go deeper on NL-OMON38402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON38402.